Cardiomyopathy
Cardiac hemochromatosis: Beneficial effects of iron removal therapy: An echocardiographic study

https://doi.org/10.1016/0002-9149(83)90422-8Get rights and content

Abstract

The echocardiographic (echo) features of idiopathic hemochromatosis (IH) were studied in 22 patients. Results were compared with a control group of 22 patients without heart disease. Statistically significant increases in left ventricular (LV) mass, end-diastolic and end-systolic diameters of the left ventricle and in left atrial dimension were observed in patients with IH; significant changes of systolic function indexes (decrease in fractional shortening and ejection fraction and increase in distance of the E point to the septum) were seen as well. These echo abnormalities were mainly seen in patients with abnormal electrocardiograms.

In 11 patients with IH, iron removal therapy was carried out by means of periodic phlebotomies. In patients with impaired LV function at the beginning of therapy, comparison between measurements of the initial echo and posttreatment echo showed significant improvement in LV diameters, fractional shortening, ejection fraction, distance from the E point to the septum, LV mass and left atrial dimension.

References (33)

  • CM Knauer et al.

    The reversal of hemochromatotic cirrhosis by multiple phlebotomies: report of a case

    Gastroenterology

    (1965)
  • LR Weintraub et al.

    The treatment of hemochromatosis by phlebotomy

    Med Clin North Am

    (1966)
  • LW Powell et al.

    Hemochromatosis

  • C Skinner et al.

    Hemochromatosis presenting as congestive cardiomyopathy and responding to venesection

    Br Heart J

    (1973)
  • M Mattheyses et al.

    La myocardiophatie de l'hémochromatose idiopatique

    Arch Mal Coeur

    (1978)
  • JF Leclercq et al.

    La myocardiopathie hémochromatosique: role bénéfique de la déplétion ferrique

    Ann Cardiol

    (1980)
  • Cited by (60)

    • Iron effects versus metabolic alterations in hereditary hemochromatosis driven bone loss

      2022, Trends in Endocrinology and Metabolism
      Citation Excerpt :

      Besides liver cirrhosis, cardiac dysfunction is the second major cause of death of patients with HH [101,102]. Phlebotomy improves cardiomyopathy, suggesting that this pathology is iron-driven [102–104]. Even though a potential association of cardiac dysfunction and osteoporosis has not yet been documented in HH, given the shared risk factors and their high prevalence in HH, future investigations into a potential interdependence of these two diseases might provide deeper insights into the pathogenesis of osteoporosis in HFE-HH.

    • Primary Restrictive, Infiltrative, and Storage Cardiomyopathies

      2020, Diastology: Clinical Approach to Heart Failure with Preserved Ejection Fraction
    • Echocardiography in Infiltrative Cardiomyopathy

      2019, Heart Lung and Circulation
      Citation Excerpt :

      Whilst CMR is the gold standard for non-invasive imaging in patients with or with suspected IOC due to its ability to determine myocardial iron content; echocardiography is a valuable tool for screening and follow-up of these patients. Patients may present with different phenotypes depending of the degree of iron overload which may include diastolic dysfunction, increased LV wall thickness, dilated cardiomyopathy and/or restrictive cardiomyopathy [86,87]. Both speckle tracking strain and TDI have demonstrated regional systolic LV and RV abnormalities in patients with IOC due to beta thalassaemia [88].

    • Spectrum of Restrictive and Infiltrative Cardiomyopathies: Part 2 of a 2-Part Series

      2018, Journal of the American College of Cardiology
      Citation Excerpt :

      After the therapeutic levels have been achieved, maintenance phlebotomy is undertaken to maintain a serum ferritin <100 mg/ml and transferrin saturation <50% (68). Improvements in cardiac function with RCM and arrhythmias have been noted if aggressive iron removal is initiated early in the disease process (69,70). Chelation therapy has been shown to be effective as an alternative option when phlebotomy is not feasible for patients who have IOC and chronic anemia or malignancy.

    • Cardiomyopathies

      2012, Principles of Echocardiography and Intracardiac Echocardiography
    View all citing articles on Scopus
    View full text